Results: 5174

Denervação renal simpática associada a reisolamento de veia pulmonar em pacientes com fibrilação atrial persistente de longa duração e hipertensão resistente: funciona?

Relato de 5 casos de pacientes com fibrilação atrial persistente de longa duração refratários ao tratamento com fármacos antiarrítmicos e submetidos a ablação da fibrilação atrial por cateter há pelo menos 12 meses. Os pacientes apresentavam as mesmas queixas, estavam utilizando os mesmos med...

Rituximab for the therapy of systemic sclerosis: a series of 10 cases in a single center

Rev. bras. reumatol; 56 (5), 2016
Abstract Systemic sclerosis (SSc) is a chronic autoimmune disease with a high morbidity and mortality. Although cyclophosphamide is effective for severe and refractory cases, there is demand for new treatments. The biological treatment with B-cell depletion with rituximab (RTX) has demonstrated efficacy ...

C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B

An. bras. dermatol; 91 (5), 2016
Abstract: Background: C-reactive protein is an inflammatory biomarker and its level increases in the serum of psoriatic patients. Its level is also associated with Psoriasis Area and Severity Index score. Objective: The aim of this study was to assess the decrement of serum C-reactive protein level wit...

Alemtuzumab in refractory Sézary syndrome

An. bras. dermatol; 91 (5), 2016
Abstract: Sézary syndrome is a primary cutaneous T-cell lymphoma characterized by the triad of erythroderma, lymphadenopathy and circulating atypical cells. The emergence of new molecular targets has enabled the development of drugs such as alemtuzumab, an anti-CD52 monoclonal antibody, which has shown ...

Primary localized cutaneous amyloidosis with lichen and poikiloderma-like lesions and an excellent response to systemic acitretin

An. bras. dermatol; 91 (5), 2016
Abstract: Primary localized cutaneous amyloidosis is a skin-limited amyloidosis that does not involve internal organs. It is clinically subclassified into 3 general categories and some rare variants. However, there is considerable overlap within the classification. Though there are a variety of therapeut...

Response of chromoblastomycosis to voriconazole

An. bras. dermatol; 91 (5), 2016
Abstract: Chromoblastomycosis is a chronic fungal infection of the epidermis, dermis and subcutaneous tissue, in which the most common etiologic agent in Brazil is Fonsecaea pedrosoi. In more advanced cases we found many difficulties in their treatment, and therefore, we report a case of extensive and se...

Nonarteritic anterior ischemic optic neuropathy following pars plana vitrectomy for macular hole treatment: case report

Arq. bras. oftalmol; 79 (5), 2016
ABSTRACT Herein, we report a case of nonarteritic anterior ischemic optic neuropathy (NAION) following uneventful pars plana vitrectomy for macular hole treatment. A 56-year-old previously healthy woman presented with a full-thickness macular hole in right eye (OD) and small cup-to-disc ratios in both ey...

Comparison of 20% sulfur hexafluoride with air for intraocular tamponade in Descemet membrane endothelial keratoplasty (DMEK)

Arq. bras. oftalmol; 79 (5), 2016
ABSTRACT Purpose: To compare the effect of 20% sulfur hexafluoride (SF6) with that of air on graft detachment rates for intraocular tamponade in Descemet membrane endothelial keratoplasty (DMEK). Methods: Forty-two eyes of patients who underwent DMEK by a single surgeon (A.S.J.) at Wilmer Eye Institute...

Management of necrotizing scleritis after pterygium surgery with rituximab

Arq. bras. oftalmol; 79 (5), 2016
ABSTRACT The authors present a case of necrotizing scleritis after pterygium excision successfully treated with rituximab after attempts with high doses of corticosteroids and immunosuppressive drugs. A literature review revealed case reports and a phase I/II dose-ranging randomized clinical trial using ...

Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for central serous chorioretinopathy

Arq. bras. oftalmol; 79 (5), 2016
ABSTRACT Purpose: To evaluate subfoveal choroidal thickness (SFCT) changes after intravitreal bevacizumab (IVB) therapy for central serous chorioretinopathy (CSC) using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT). Methods: In this retrospective study, we assessed the m...